Business
‘Robust immune responses’: Oxford virus trial offers hope for elderly – The New Daily
Oxford University-AstraZeneca’s coronavirus vaccine has produced a robust immune response in elderly people, according to early test results.
The COVID-19 vaccine being developed by the University of Oxford produces an immune response in both elderly and young people and adverse reactions were lower among the elderly, British drug maker AstraZeneca says.
A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.
The Financial Times reported the vaccine, being developed by Oxford and AstraZeneca,…
-
General10 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
Noosa News15 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General22 hours agoLiberals offer help to start-ups and set goal for small business growth
-
Business15 hours agoWhere to invest $20,000 into ASX 200 shares after the market selloff